Stay updated on GSK2857916 Dose Escalation Clinical Trial

Sign up to get notified when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GSK2857916 Dose Escalation Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.1%
    Check dated 2025-05-08T05:03:45.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-05-01T01:24:48.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant content removal regarding a clinical study on GSK2857916 for Multiple Myeloma, including detailed descriptions of the study's purpose, methodology, and eligibility criteria. The only notable addition is the mention of the EudraCT number and a revision update.
    Difference
    13%
    Check dated 2025-04-16T14:11:35.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T08:45:27.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T22:58:43.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-03-18T08:40:11.000Z thumbnail image

Stay in the know with updates to GSK2857916 Dose Escalation Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.